The gut microbiota is increasingly recognized as an important factor in disease development, progression and treatment response. This Review highlights the promise of strategies that target the gut microbiome in the treatment of disease, including cancer and infectious and metabolic diseases.
- Daniel A. Schupack
- Ruben A. T. Mars
- Purna C. Kashyap
